ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 176 filers reported holding ZAI LAB LTD in Q3 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,380,079 | -10.1% | 56,770 | +2.5% | 0.01% | 0.0% |
| Q2 2023 | $1,535,410 | -13.8% | 55,370 | +3.4% | 0.01% | -25.0% |
| Q1 2023 | $1,781,738 | +11.5% | 53,570 | +2.9% | 0.01% | 0.0% |
| Q4 2022 | $1,598,549 | -1.1% | 52,070 | +10.2% | 0.01% | -11.1% |
| Q3 2022 | $1,617,000 | +4.1% | 47,270 | +5.6% | 0.01% | +12.5% |
| Q2 2022 | $1,553,000 | -1.6% | 44,770 | +24.8% | 0.01% | 0.0% |
| Q1 2022 | $1,578,000 | -29.2% | 35,870 | +1.1% | 0.01% | -11.1% |
| Q4 2021 | $2,229,000 | -22.4% | 35,470 | +30.1% | 0.01% | -30.8% |
| Q3 2021 | $2,874,000 | -27.4% | 27,270 | +21.9% | 0.01% | -23.5% |
| Q2 2021 | $3,959,000 | +36.3% | 22,370 | +2.8% | 0.02% | +21.4% |
| Q1 2021 | $2,905,000 | -3.6% | 21,770 | -2.2% | 0.01% | -12.5% |
| Q4 2020 | $3,014,000 | +105.0% | 22,270 | +26.0% | 0.02% | +77.8% |
| Q3 2020 | $1,470,000 | +1.3% | 17,670 | 0.0% | 0.01% | 0.0% |
| Q2 2020 | $1,451,000 | +117.2% | 17,670 | +36.2% | 0.01% | +80.0% |
| Q1 2020 | $668,000 | – | 12,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |